🚚 FREE U.S. Shipping on Orders Over $500
SKU: Ipamorelin-10mg

IPAMORELIN (10mg)

Ipamorelin is a synthetic pentapeptide with the sequence Aib-His-D-2-Nal-D-Phe-Lys-NH₂, produced by solid-phase peptide synthesis. It contains the unnatural residues alpha-aminoisobutyric acid (Aib) and 2-naphthylalanine, two D-amino acid substitutions, and a C-terminal amide.

It was identified in the 1990s from a series of compounds built around the growth hormone-releasing peptide scaffold. In published literature, ipamorelin has been characterized as a ligand of the growth hormone secretagogue receptor subtype 1a (GHS-R1a), the receptor for ghrelin, and it is distinguished within its class by reported selectivity for that receptor relative to earlier GHRP-scaffold compounds. That selectivity makes it a frequent reference ligand in growth hormone secretagogue pharmacology.

This material is supplied as a characterized reference compound for non-clinical laboratory work, such as analytical method development, GHS-R1a receptor binding and cAMP or calcium-flux assays, somatotroph cell culture assays, and comparative structure-activity and selectivity studies across the GHRP series.

Compound Specifications

Property Value
Amino Acid Sequence Aib-His-D-2-Nal-D-Phe-Lys-NH₂
Sequence Length 5 residues (pentapeptide)
Molecular Formula C₃₈H₄₉N₉O₅
Molecular Weight ~711.9 g/mol
Monoisotopic Mass 711.3857 Da
CAS Number 170851-70-4
Physical Form Lyophilized powder

Storage & Handling
Store lyophilized powder at −20 °C, protected from light. Avoid moisture and repeated freeze-thaw cycles. Handle in accordance with standard laboratory safety practices.

FOR RESEARCH USE ONLY. Not for human consumption. Not intended for human or veterinary use. For laboratory research and analytical purposes only.

$85.00

Choose Quantity

Description

Ipamorelin is a synthetic pentapeptide with the sequence Aib-His-D-2-Nal-D-Phe-Lys-NH₂, produced by solid-phase peptide synthesis. It contains the unnatural residues alpha-aminoisobutyric acid (Aib) and 2-naphthylalanine, two D-amino acid substitutions, and a C-terminal amide.

It was identified in the 1990s from a series of compounds built around the growth hormone-releasing peptide scaffold. In published literature, ipamorelin has been characterized as a ligand of the growth hormone secretagogue receptor subtype 1a (GHS-R1a), the receptor for ghrelin, and it is distinguished within its class by reported selectivity for that receptor relative to earlier GHRP-scaffold compounds. That selectivity makes it a frequent reference ligand in growth hormone secretagogue pharmacology.

This material is supplied as a characterized reference compound for non-clinical laboratory work, such as analytical method development, GHS-R1a receptor binding and cAMP or calcium-flux assays, somatotroph cell culture assays, and comparative structure-activity and selectivity studies across the GHRP series.

Compound Specifications

Property Value
Amino Acid Sequence Aib-His-D-2-Nal-D-Phe-Lys-NH₂
Sequence Length 5 residues (pentapeptide)
Molecular Formula C₃₈H₄₉N₉O₅
Molecular Weight ~711.9 g/mol
Monoisotopic Mass 711.3857 Da
CAS Number 170851-70-4
Physical Form Lyophilized powder

Storage & Handling
Store lyophilized powder at −20 °C, protected from light. Avoid moisture and repeated freeze-thaw cycles. Handle in accordance with standard laboratory safety practices.

FOR RESEARCH USE ONLY. Not for human consumption. Not intended for human or veterinary use. For laboratory research and analytical purposes only.

Additional information

Weight 0.1 lbs
Dimensions 1 × 1 × 2 in

Disclaimer: For Research Purposes Only

This content is supplied exclusively for research and educational purposes. Nothing presented here should be interpreted as approval, promotion, or encouragement of any non-laboratory use, improper handling, or non-research application of peptides intended for scientific investigation. Any references to specific peptides, their properties, or findings associated with them are provided solely as informational research content. This information does not constitute legal advice, clinical guidance, or a recommendation for personal, therapeutic, or non-research use. These compounds are intended only for controlled scientific work conducted by qualified and authorized individuals. Before making any decision regarding the purchase, possession, handling, or use of research peptides, consultation with qualified research professionals or legal counsel is strongly advised. All information should be used responsibly, ethically, and only in connection with legitimate academic, scientific, or investigative purposes. This notice applies broadly to all peptide-related content provided here and may be updated as needed.

0